Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Safe Supply Announces Strategic Expansion into AI-Powered Healthcare Solutions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Crescita Therapeutics Inc T.CTX

Alternate Symbol(s):  CRRTF

Healthcare
Crescita Therapeutics Inc. is a commercial dermatology company with in-house research and development (R&D) and manufacturing capabilities. It offers a portfolio of science-based non-prescription skincare products and early to commercial stage prescription products. It operates in three segments: Commercial Skincare, Licensing and Royalties and Manufacturing and Services. The Commercial... see more

TSX:CTX - Post Discussion

Crescita Therapeutics Inc > Q3 - strong performance
View:
Post by bingostar on Nov 12, 2020 8:34am

Q3 - strong performance

https://www.prnewswire.com/news-releases/crescita-reports-third-quarter-2020-results-301171830.html
Comment by mrleao on Nov 12, 2020 11:18am
Perfect timing to buy. Heading to $2!
Comment by Daydream2 on Nov 12, 2020 12:11pm
All good,   Plus, here's 2 important future catalysts to look for in the comming months: 1. Anticipated launch by Sundial Growers of cannabinoid products using CTX’s MMPE™ technology 2. CTX-101 outlicensing. CTX-101 is a topical corticosteroid for plaque psoriasis. Crescita is responsible for formulation development / IP and providing its proprietary MMPE™  ...more  
Comment by mrleao on Nov 12, 2020 4:57pm
Finally good news. Congratulations to the longs
Crescita Therapeutics Inc
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities